STAT Plus: Plasma giant Grifols to buy Silicon Valley startup targeting blood proteins for age-related diseases
Grifols agreed to buy Alkahest, a startup that’s betting that proteins in plasma can fight diseases including Alzheimer’s and Parkinson’s.
No hay comentarios:
Publicar un comentario